Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Infectious Disease Testing: A Rapidly Growing and Challenging Market Facing SuppliersA new comprehensive seven-country report designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market in evaluating emerging opportunities.
To review this report, please visit:http://www.vpgmarketresearch.com/ Rationale This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies. Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products. Worldwide Market Overview - Estimated universe of laboratories performing infectious disease testing by country. - Test volume and sales projections for major infectious disease diagnostic assays by country. Opportunities and Strategic Recommendations - Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years. - Design criteria for decentralized testing products. - Alternative market penetration strategies. - Potential market entry barriers and risks. Infectious Diseases Analyzed in the Report AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia. Market Segmentation Analysis - Sales and market shares of major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by country, individual test and market segment: ° Hospitals ° Blood Banks ° Commercial/Private Laboratories ° Physician Offices/Group Practices ° Public Health Laboratories - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/ - Review of the market dynamics, trends, structure, size, growth and major suppliers by country. Current and Emerging Products - In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs. - Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices. Technology Review - Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing. - Global listings of companies developing or marketing infectious disease diagnostic products by individual test. Competitive Assessments - Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Contains 1,900 pages and 850 tables To review these and related infectious disease market reports, please visit: http://www.vpgmarketresearch.com/ For further details or questions regarding tour reports, please contact: Robert Fisher Robert@vpgcorp.com +1 212 564 2838 http://www.VPGMarketResearch.com http://www.LeadingMarketResearch.com End
Account Email Address Account Phone Number Disclaimer Report Abuse Page Updated Last on: Jul 16, 2014
|
|